Ribavirin Causes Error Catastrophe during Hantaan Virus Replication

作者: William E. Severson , Connie S. Schmaljohn , Ali Javadian , Colleen B. Jonsson

DOI: 10.1128/JVI.77.1.481-488.2003

关键词:

摘要: Except for ribavirin, no other antiviral drugs treating hantaviral diseases have been identified. It is well established that ribavirin will inhibit the production of infectious Hantaan virus (HTNV); however, its mechanism action unknown. To characterize inhibitory effect on HTNV, levels viral RNAs, proteins, and particles were measured 3 days posttreatment HTNV-infected Vero E6 cells. cells treated with showed a slight reduction in cRNA, RNA, mRNA populations first day postinfection. The amount cRNA RNA increased to observed untreated 2, whereas more greatly reduced 2 3. Despite finding S-segment mRNA, albeit low, three proteins—nucleocapsid (N) protein glycoproteins G1 G2—could not be detected by immunohistochemistry ribavirin-treated test hypothesis these effects caused incorporation into nascent resultant “error catastrophe” was occurring, we cloned sequenced cRNA/mRNA from or We found high mutation frequency (9.5/1,000 nucleotides) synthesized presence ribavirin. Hence, transcripts produced drug functional. These results suggest ribavirin's lies challenging fidelity hantavirus polymerase, which causes error catastrophe.

参考文章(24)
B. R. Shiels, W. Northemann, S. Broome, G. Widera, G. D. Virca, Simplified northern blot hybridization using 5% sodium dodecyl sulfate. BioTechniques. ,vol. 8, pp. 370- 371 ,(1990)
Stephen S. Morse, The evolutionary biology of viruses New York. ,(1994)
Shane Crotty, David Maag, Jamie J. Arnold, Weidong Zhong, Johnson Y. N. Lau, Zhi Hong, Raul Andino, Craig E. Cameron, The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Medicine. ,vol. 6, pp. 1375- 1379 ,(2000) , 10.1038/82191
Biswendu B. Goswami, Ernest Borek, Opendra K. Sharma, James Fujitaki, Roberts A. Smith, The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochemical and Biophysical Research Communications. ,vol. 89, pp. 830- 836 ,(1979) , 10.1016/0006-291X(79)91853-9
J. W. Huggins, C. M. Hsiang, T. M. Cosgriff, M. Y. Guang, J. I. Smith, Z. O. Wu, J. W. LeDuc, Z. M. Zheng, J. M. Meegan, Q. N. Wang, D. D. Oland, X. E. Gui, P. H. Gibbs, G. H. Yuan, T. M. Zhang, Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome The Journal of Infectious Diseases. ,vol. 164, pp. 1119- 1127 ,(1991) , 10.1093/INFDIS/164.6.1119
Robert E. Lanford, Deborah Chavez, Bernadette Guerra, J. Y. N. Lau, Zhi Hong, Kathleen M. Brasky, Burton Beames, Ribavirin Induces Error-Prone Replication of GB Virus B in Primary Tamarin Hepatocytes Journal of Virology. ,vol. 75, pp. 8074- 8081 ,(2001) , 10.1128/JVI.75.17.8074-8081.2001
S. L. Ruo, A. Sanchez, L. H. Elliott, L. S. Brammer, J. B. McCormick, S. P. Fisher-Hoch, Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Archives of Virology. ,vol. 119, pp. 1- 11 ,(1991) , 10.1007/BF01314318
Susan K. Wray, Brian E. Gilbert, Vernon Knight, Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro Antiviral Research. ,vol. 5, pp. 39- 48 ,(1985) , 10.1016/0166-3542(85)90013-0